Oncology Ablation Market Growth Driven By Increasing Cancer Diagnosis Rates

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Oncology Ablation Market Expected To Scale Between 2026 And 2030?

The oncology ablation market size has experienced rapid growth in recent years. This market is projected to expand from $1.45 billion in 2025 to $1.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. Historically, this growth has been driven by factors such as the increasing prevalence of liver, kidney, and lung cancers, a heightened demand for minimally invasive treatments, the wider availability of advanced imaging technologies, the expansion of hospitals and dedicated oncology centers, and a growing understanding of ablation as a viable alternative to surgical procedures.

The oncology ablation market size is projected to experience substantial growth in the coming years, anticipated to reach $2.61 billion by 2030 at a compound annual growth rate (CAGR) of 12.4%. This expansion during the forecast period is attributed to several factors, including the increase in targeted and personalized ablation therapies, the rising adoption of percutaneous and laparoscopic ablation techniques, ongoing technological advancements in ablation equipment, the expansion of oncology centers in emerging regions, and the growing integration of digital patient management and monitoring systems. Key trends for the forecast period include the increasing adoption of digital platforms for managing oncology ablation procedures, the expanding integration of AI and machine learning in tumor diagnosis and planning, the broader implementation of precision medicine and genomic profiling for ablation therapy, the rising automation in ablation devices and surgical equipment, and the increasing use of IoT-enabled monitoring for ablation devices and patient outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Factors Are Contributing To The Growth Of The Oncology Ablation Market?

The expanding volume of cancer diagnoses is anticipated to fuel the expansion of the oncology ablation market in the foreseeable future. Cancer diagnosis involves identifying and confirming cancer’s presence through various methods, including medical tests, imaging techniques, and the pathological analysis of tissue samples. This surge in diagnoses stems from multiple contributors like aging demographics, enhanced screening initiatives, increased public awareness prompting earlier detection, and environmental influences. Oncology ablation addresses tumors identified via these diagnoses, providing minimally invasive approaches to eliminate tumors and enhance patient outcomes. Illustratively, data from May 2024 by the National Cancer Institute, the primary US federal agency for cancer research and training, projects approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in men. Furthermore, by 2040, the yearly count of new cancer cases is predicted to climb to 29.9 million, underscoring a substantial rise in future cancer occurrences. Additionally, in June 2022, the American Cancer Society, a US non-profit dedicated to cancer awareness, reported about 1.9 million new cancer cases diagnosed in the USA in 2022. Consequently, the growing volume of cancer diagnoses will serve as a key driver for the oncology ablation market.

How Is The Oncology Ablation Market Organized By Segment Classification?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Trends Are Shaping The Future Of The Oncology Ablation Market?

Leading companies within the oncology ablation market are introducing innovative products, including advanced ablation systems offering enhanced precision, integrated imaging solutions for real-time guidance, and improved safety functionalities. These advanced ablation systems with improved precision are medical instruments that employ cutting-edge technology to accurately pinpoint and eliminate abnormal tissue, like tumors, thereby reducing harm to adjacent healthy tissue. As an illustration, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, secured US Food and Drug Administration approval for its OsteoCool 2.0 bone tumor ablation system, which is engineered to address painful bone metastases and benign tumors such as osteoid osteoma. The upgraded system incorporates substantial improvements, notably the capacity to simultaneously utilize four internally cooled probes, facilitating the ablation of two vertebral bodies concurrently or the generation of larger ablation zones in non-spinal contexts.

Who Are The Industry Participants Involved In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Get The Full Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Geographic Region Dominates The Oncology Ablation Market?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oncology Ablation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795